1.0
Nov 2, 2023
Anonymous employee
Former employee, more than 3 years
Mechelen
Recommend
CEO approval
Business Outlook
Pros
Ability to hybrid work. Potential of new CEO .. but this is also waning Gilead involvement and knowledge to steer Galapagos In past had talented but all left
Cons
Poor commercial leadership CCO CCO not experienced . Inflamm pipeline halted due to his lack of experience . Had only worked with Abbvie hence unaware how to launch in todays environment .